Literature DB >> 29454190

Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors.

Loredana Salerno1, Emanuele Amata1, Giuseppe Romeo1, Agostino Marrazzo1, Orazio Prezzavento1, Giuseppe Floresta2, Valeria Sorrenti1, Ignazio Barbagallo1, Antonio Rescifina3, Valeria Pittalà4.   

Abstract

Here we report the design, synthesis, and molecular modeling of new potent and selective imidazole-based HO-1 inhibitors in which the imidazole nucleus and the hydrophobic groups are linked by a phenylethanolic spacer. Most of the tested compounds showed a good inhibitor activity with IC50 values in the low micromolar range, with two of them (1b and 1j) exhibiting also high selectivity toward HO-2. These results were obtained by the idea of potholing the entire volume of the principal hydrophobic western region with an appropriate ligand volume. Molecular modeling studies showed that these molecules bind to the HO-1 in the consolidated fashion where the imidazolyl moiety coordinates the heme iron while the aromatic groups are stabilized by hydrophobic interaction in the western region of the binding pocket. Finally, the synthesized compounds were analyzed for in silico ADME-Tox properties to establish oral drug-like behavior and showed satisfactory results.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ADME-Toxicity; Docking studies; HO-1 imidazole inhibitors; Heme oxygenase-1 western region; In silico profiling

Mesh:

Substances:

Year:  2018        PMID: 29454190     DOI: 10.1016/j.ejmech.2018.02.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  11 in total

1.  Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib.

Authors:  Ignazio Barbagallo; Cesarina Giallongo; Giovanni Li Volti; Alfio Distefano; Giuseppina Camiolo; Marco Raffaele; Loredana Salerno; Valeria Pittalà; Valeria Sorrenti; Roberto Avola; Michelino Di Rosa; Luca Vanella; Francesco Di Raimondo; Daniele Tibullo
Journal:  Mol Neurobiol       Date:  2018-06-10       Impact factor: 5.590

2.  Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation.

Authors:  Mariarita Spampinato; Giuseppe Sferrazzo; Valeria Pittalà; Michelino Di Rosa; Luca Vanella; Loredana Salerno; Valeria Sorrenti; Giuseppe Carota; Nunziatina Parrinello; Marco Raffaele; Daniele Tibullo; Giovanni Li Volti; Ignazio Barbagallo
Journal:  Mol Biol Rep       Date:  2020-02-13       Impact factor: 2.316

3.  Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.

Authors:  Khaled F Greish; Loredana Salerno; Reem Al Zahrani; Emanuele Amata; Maria N Modica; Giuseppe Romeo; Agostino Marrazzo; Orazio Prezzavento; Valeria Sorrenti; Antonio Rescifina; Giuseppe Floresta; Sebastiano Intagliata; Valeria Pittalà
Journal:  Molecules       Date:  2018-05-18       Impact factor: 4.411

4.  A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands.

Authors:  Giuseppe Floresta; Emanuele Amata; Carla Barbaraci; Davide Gentile; Rita Turnaturi; Agostino Marrazzo; Antonio Rescifina
Journal:  Mar Drugs       Date:  2018-10-14       Impact factor: 5.118

Review 5.  Heme Oxygenase-1 in Central Nervous System Malignancies.

Authors:  Giuseppe Sferrazzo; Michelino Di Rosa; Eugenio Barone; Giovanni Li Volti; Nicolò Musso; Daniele Tibullo; Ignazio Barbagallo
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

6.  New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.

Authors:  Valeria Ciaffaglione; Sebastiano Intagliata; Valeria Pittalà; Agostino Marrazzo; Valeria Sorrenti; Luca Vanella; Antonio Rescifina; Giuseppe Floresta; Ameera Sultan; Khaled Greish; Loredana Salerno
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

7.  Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.

Authors:  Giuseppe Floresta; Davide Gentile; Giancarlo Perrini; Vincenzo Patamia; Antonio Rescifina
Journal:  Mar Drugs       Date:  2019-10-31       Impact factor: 5.118

8.  Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.

Authors:  Giuseppe Romeo; Valeria Ciaffaglione; Emanuele Amata; Maria Dichiara; Loredana Calabrese; Luca Vanella; Valeria Sorrenti; Salvo Grosso; Agata Grazia D'Amico; Velia D'Agata; Sebastiano Intagliata; Loredana Salerno
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

9.  iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer.

Authors:  Agostino Cilibrizzi; Giuseppe Floresta; Vincenzo Abbate; Maria Paola Giovannoni
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

10.  From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes.

Authors:  Giuseppe Floresta; Antonino Nicolò Fallica; Vincenzo Patamia; Valeria Sorrenti; Khaled Greish; Antonio Rescifina; Valeria Pittalà
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.